Evotec SE
Evotec SE (EVOTF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EVOTF · as of Jun 8, 2026
Key Statistics
Explore Evotec SE Data
evotf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 50.0%
Competitors & Peers
evotf competitorsEVOTF
BIOGY
CHIZF
CMOPF
GNMLF
KSPHFStock Performance
Full HistoryAbout Evotec SE
Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas…
what is evotec se · evotf stock overview · evotec se company profile · who is evotec se ceo · evotf OTC · evotec se headquarters · evotec se business segments
About Stock Overview & Key Data
Evotec SE (EVOTF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Oct 7, 2009. As of the latest trading session, EVOTF stock price is $6.69, with a market capitalization of $1.2B. The stock has returned -19.11% over the past 12 months and -16.48% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Evotec SE stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Evotec SE reported revenue of $788.1M and net income of -$103.5M. For detailed data — including Evotec SE revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Evotec SE (EVOTF) stock price is $6.69. The stock is traded on OTC under the ticker symbol EVOTF. The 52-week range is $4.72 – $8.58.